Search research articles
Contact Us
Filters
Showing results (151-160 of 219) with videos related to
Page
of 22
Sort By:
World Journal of Hepatology
|
January 14, 2021
Validation of genetic variants associated with metabolic dysfunction-associated fatty liver disease in an ethnic Chinese population
Guan Huei Lee, Wah Wah Phyo, Wai Mun Loo, et al.
Antiviral Therapy
|
April 28, 2006
A randomized, placebo-controlled trial of thymosin-alpha1 and lymphoblastoid interferon for HBeAg-positive chronic hepatitis B
Seng Gee Lim, Chun-too Wai, Yin Mei Lee, et al.
Archives of Internal Medicine
|
January 13, 2006
A double-blind placebo-controlled study of emtricitabine in chronic hepatitis B
Seng Gee Lim, Tay Meng Ng, Nelson Kung, et al.
World Journal of Hepatology
|
July 12, 2019
Risk factors for ribavirin treatment failure in Asian organ transplant recipients with chronic hepatitis E infection
En Xian Sarah Low, Edhel Tripon, Kieron Lim, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
December 19, 2020
Predicting HCC Response to Multikinase Inhibitors With In Vivo Cirrhotic Mouse Model for Personalized Therapy
Daniel Q Huang, Mark D Muthiah, Lei Zhou, et al.
Alimentary Pharmacology & Therapeutics
|
August 12, 2025
Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment
Grace Lai-Hung Wong, Edward Gane, Calvin Q Pan, et al.
Journal of Gastroenterology and Hepatology
|
April 27, 2025
Head-to-Head Comparison of Long-Term HCC Risk of Antivirals-Treated Versus Untreated Low-Level Viremia in HBV-Compensated Cirrhosis
Nobuharu Tamaki, Daniel Q Huang, Hyung Woong Lee, et al.
The Journal of Clinical Investigation
|
January 9, 2018
Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation
Laura Rivino, Nina Le Bert, Upkar S Gill, et al.
Journal of Gastroenterology and Hepatology
|
August 12, 2004
Practical difficulties in the management of hepatitis B in the Asia-Pacific region
Rosmawati Mohamed, Paul Desmond, Dong-Jin Suh, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 25, 2024
Single-cell RNA sequencing reveals anti-tumor potency of CD56<sup>+</sup> NK cells and CD8<sup>+</sup> T cells in humanized mice via PD-1 and TIGIT co-targeting
Wai Nam Liu, Sarah L Harden, Shawn Lu Wen Tan, et al.
Page
of 22
Search research articles
Search
Showing results (151-160 of 219) with videos related to
Sort By:
Page
of 22
World Journal of Hepatology
|
January 14, 2021
Validation of genetic variants associated with metabolic dysfunction-associated fatty liver disease in an ethnic Chinese population
Guan Huei Lee, Wah Wah Phyo, Wai Mun Loo, et al.
Antiviral Therapy
|
April 28, 2006
A randomized, placebo-controlled trial of thymosin-alpha1 and lymphoblastoid interferon for HBeAg-positive chronic hepatitis B
Seng Gee Lim, Chun-too Wai, Yin Mei Lee, et al.
Archives of Internal Medicine
|
January 13, 2006
A double-blind placebo-controlled study of emtricitabine in chronic hepatitis B
Seng Gee Lim, Tay Meng Ng, Nelson Kung, et al.
World Journal of Hepatology
|
July 12, 2019
Risk factors for ribavirin treatment failure in Asian organ transplant recipients with chronic hepatitis E infection
En Xian Sarah Low, Edhel Tripon, Kieron Lim, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
December 19, 2020
Predicting HCC Response to Multikinase Inhibitors With In Vivo Cirrhotic Mouse Model for Personalized Therapy
Daniel Q Huang, Mark D Muthiah, Lei Zhou, et al.
Alimentary Pharmacology & Therapeutics
|
August 12, 2025
Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment
Grace Lai-Hung Wong, Edward Gane, Calvin Q Pan, et al.
Journal of Gastroenterology and Hepatology
|
April 27, 2025
Head-to-Head Comparison of Long-Term HCC Risk of Antivirals-Treated Versus Untreated Low-Level Viremia in HBV-Compensated Cirrhosis
Nobuharu Tamaki, Daniel Q Huang, Hyung Woong Lee, et al.
The Journal of Clinical Investigation
|
January 9, 2018
Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation
Laura Rivino, Nina Le Bert, Upkar S Gill, et al.
Journal of Gastroenterology and Hepatology
|
August 12, 2004
Practical difficulties in the management of hepatitis B in the Asia-Pacific region
Rosmawati Mohamed, Paul Desmond, Dong-Jin Suh, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 25, 2024
Single-cell RNA sequencing reveals anti-tumor potency of CD56<sup>+</sup> NK cells and CD8<sup>+</sup> T cells in humanized mice via PD-1 and TIGIT co-targeting
Wai Nam Liu, Sarah L Harden, Shawn Lu Wen Tan, et al.
Page
of 22